Organogenesis Holdings
ORGO
136 hedge funds and large institutions have $281M invested in Organogenesis Holdings in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 11 closing their positions.
145% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 11
145% more call options, than puts
Call options by funds: $299K | Put options by funds: $122K
40% more capital invested
Capital invested by funds: $200M → $281M (+$80.4M)
13% more funds holding
Funds holding: 120 → 136 (+16)
1.45% more ownership
Funds ownership: 49.76% → 51.21% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.25M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.83M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.4M |
| 4 |
SG Americas Securities
New York
|
+$1.95M |
| 5 |
Lazard Asset Management
New York
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$10.6M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.03M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.54M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.13M |
| 5 |
Goldman Sachs
New York
|
-$945K |
ORGO Hedge Fund Activity: Q1 2025 in Review
136 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2025, worth a combined $281M — up 40% from $200M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ORGO positions and 11 closed out — a net gain of 16 holders — while 45 added to existing stakes and 47 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $7.25M. The largest seller was Assenagon Asset Management, cutting an estimated $10.6M.
- 136 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2025, up from 120 in Q4 2024.
- Funds reported $281M of Organogenesis Holdings stock for Q1 2025, up 40% quarter-over-quarter.
- 27 funds opened new Organogenesis Holdings positions in Q1 2025 and 11 closed out, a net change of +16 holders.
- The largest Organogenesis Holdings buyer in Q1 2025 was Driehaus Capital Management, an estimated $7.25M added.
- The largest Organogenesis Holdings seller in Q1 2025 was Assenagon Asset Management, an estimated $10.6M sold.
Based on aggregated 13F filings for Q1 2025.